| |
 |
|
Class Information
Number: 514/45
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai > N-glycoside > Nitrogen containing hetero ring > Purines (including hydrogenated) (e.g., adenine, guanine, etc.)
Description:
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625875 |
2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Dec. 1, 2009 |
| 7625872 |
Branched immunomodulatory compounds and methods of using the same |
Dec. 1, 2009 |
| 7625876 |
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
Dec. 1, 2009 |
| 7618949 |
Drug-eluting stents coated with P2Y.sub.12 receptor antagonist compound |
Nov. 17, 2009 |
| 7615539 |
Nucleic acid-lipophilic conjugates |
Nov. 10, 2009 |
| 7612047 |
Degradation-resistant mononucleoside phosphate compounds |
Nov. 3, 2009 |
| 7608597 |
Methods and compositions for treating hepatitis C virus |
Oct. 27, 2009 |
| 7608600 |
Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
Oct. 27, 2009 |
| 7605143 |
2-propynyl adenosine analogs with modified 5'-ribose groups having A.sub.2A agonist activity |
Oct. 20, 2009 |
| 7605137 |
Combination therapy comprising cloretazine |
Oct. 20, 2009 |
| 7601701 |
Compounds for the treatment of tobacco dependence and withdrawal |
Oct. 13, 2009 |
| 7595305 |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
Sep. 29, 2009 |
| 7592326 |
Method for stimulating the immune, inflammatory or neuroprotective response |
Sep. 22, 2009 |
| 7589075 |
Use of an adenosine A3 receptor agonist for inhibition of viral replication |
Sep. 15, 2009 |
| 7582616 |
Nucleoside transport inhibitors |
Sep. 1, 2009 |
| 7579331 |
Method of improved diuresis in individuals with impaired renal function |
Aug. 25, 2009 |
| 7576068 |
Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
Aug. 18, 2009 |
| 7576069 |
2-polycyclic propynyl adenosine analogs having A2A agonist activity |
Aug. 18, 2009 |
| 7569555 |
Method for stimulating the immune, inflammatory or neuroprotective response |
Aug. 4, 2009 |
| 7566702 |
Immunostimulatory oligonucleotide multimers |
Jul. 28, 2009 |
| 7566703 |
Semi-soft C-class immunostimulatory oligonucleotides |
Jul. 28, 2009 |
| 7557093 |
Composition for promoting collagen production |
Jul. 7, 2009 |
| 7557092 |
Purinergic modulation of smell |
Jul. 7, 2009 |
| 7553823 |
C-pyrazole A2A receptor agonists |
Jun. 30, 2009 |
| 7550442 |
Nucleoside analog inhibitors of reverse transcriptase |
Jun. 23, 2009 |
| 7521432 |
Compositions and methods for identifying agents which regulate chromosomal stability, gene activation and aging |
Apr. 21, 2009 |
| 7517862 |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
Apr. 14, 2009 |
| 7514417 |
A.sub.1 adenosine receptor agonists |
Apr. 7, 2009 |
| 7514413 |
In-vivo energy depleting strategies for killing drug-resistant cancer cells |
Apr. 7, 2009 |
| 7504243 |
Methods for the production of biliverdin |
Mar. 17, 2009 |
| 7488720 |
A.sub.1 adenosine receptor agonists |
Feb. 10, 2009 |
| 7468357 |
Nucleosides with anti-hepatitis B virus activity |
Dec. 23, 2008 |
| 7462604 |
Hair growth promotor composition |
Dec. 9, 2008 |
| 7452870 |
Drug-eluting stents coated with P2Y.sub.12 receptor antagonist compound |
Nov. 18, 2008 |
| 7435724 |
Degradation-resistant mononucleoside phosphate compounds |
Oct. 14, 2008 |
| 7432272 |
Antiviral analogs |
Oct. 7, 2008 |
| 7429570 |
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
Sep. 30, 2008 |
| 7429569 |
Compositions and methods for the regulation of homocysteine levels within the body |
Sep. 30, 2008 |
| 7429571 |
Therapeutic furopyrimidines and thienopyrimidines |
Sep. 30, 2008 |
| 7425546 |
Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
Sep. 16, 2008 |
| 7407944 |
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
Aug. 5, 2008 |
| 7399754 |
N.sup.2-quinoline or isoquinoline substituted purine derivatives |
Jul. 15, 2008 |
| 7396825 |
Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
Jul. 8, 2008 |
| 7390782 |
Methods and products related to metabolic interactions in disease |
Jun. 24, 2008 |
| 7381713 |
Treatment of cancer by reduction of intracellular energy and pyrimidines |
Jun. 3, 2008 |
| 7378401 |
Use of Fosfluridine Tidoxil (FT) for the treatment of intraepithelial proliferative diseases |
May. 27, 2008 |
| 7374783 |
Powders coated with specific lipoamino acid composition and cosmetics containing the same |
May. 20, 2008 |
| 7375094 |
Methods for decreasing or preventing pain using spicamycin derivatives |
May. 20, 2008 |
| 7371737 |
2-substituted-6-trifluoromethyl purine derivatives with adenosine-A.sub.3 antagonistic activity |
May. 13, 2008 |
| 7368437 |
Bicyclic heterocycles, processes for their preparation and their use as herbicides and pharmaceutical agents |
May. 6, 2008 |
|
|
|
